Malignant Tumor Clinical Trial
Official title:
Efficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant Biliary Obstruction: A Multicenter Prospective Randomized Trial
Previous studies indicated that covered stents are less likely to become occluded in comparison to bare stents. While the probability of occlusions caused by tumor in-growth is less in covered stents, they are more likely to spontaneously migrate to a position that is distal to the original deployment site. However, newer covered stents with improved designs, such as the partially covered double bare metallic stent used for this study, include features to mitigate the migration issue. The purpose of this study is to confirm whether the difference in patency rate between regular covered stents and bare stents, which has already been well established by existing studies, is also reproducible when double covered stents are compared against double bare stents.
Malignant obstructive jaundice is a common complication of advanced stage cholangiocarcinoma, GB cancer, and pancreatic cancer. In biliary stricture by malignancy, biliary drainage with placement of self-expanding metal stent (SEMS) for palliation is the therapy of choice in these patients. When compared to plastic stents, SEMS present a significantly decreased risk of recurrent biliary obstruction. SEMS are also more cost-effective than plastic stents in patients with a life expectancy of longer than 4 months. However, despite their numerous benefits, SEMS become occluded in up to 50 % of patients in the first 6-8 months. In order to minimize the occurrence of this issue, covered stents were developed. Previous studies indicated that covered stents are less likely to become occluded in comparison to bare stents. While the probability of occlusions caused by tumor in-growth is less in covered stents, they are more likely to spontaneously migrate to a position that is distal to the original deployment site. However, newer covered stents with improved designs, such as the partially covered double bare metallic stent used for this study, include features to mitigate the migration issue. The purpose of this study is to confirm whether the difference in patency rate between regular covered stents and bare stents, which has already been well established by existing studies, is also reproducible when double covered stents are compared against double bare stents. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04691349 -
CAR-T for r/r Malignant Tumors in Children
|
Early Phase 1 | |
Recruiting |
NCT04672473 -
Treatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and Decitabine
|
Phase 1/Phase 2 | |
Recruiting |
NCT06080984 -
The Application of Novel Oncolytic Virus in Late Stage Solid Tumors
|
Phase 1 | |
Recruiting |
NCT04991506 -
A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT02552004 -
Assessment of Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery: a Pilot Study
|
N/A | |
Recruiting |
NCT05280873 -
Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP
|
Phase 1 | |
Completed |
NCT06093945 -
Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT05592262 -
Pharmacokinetic Test of High-fat Diet After Oral Administration of SHR2554 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03012945 -
Epidural Anesthesia-analgesia and Long-term Outcome
|
N/A | |
Recruiting |
NCT04686682 -
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06084767 -
68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer
|
N/A | |
Completed |
NCT03354741 -
Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in Children
|
N/A | |
Recruiting |
NCT03931720 -
Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor
|
Phase 1/Phase 2 | |
Completed |
NCT01906632 -
Gene Expression Profiling of Malignant Tumor Predict the Therapeutic Response of DC-CIK Immunotherapy
|
N/A | |
Recruiting |
NCT05596344 -
Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors
|
||
Active, not recruiting |
NCT04230200 -
Prospective Screening Programme for Malignant Tumors
|
||
Completed |
NCT04730843 -
A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT04952766 -
Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults
|
Phase 4 | |
Recruiting |
NCT05781555 -
A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors
|
N/A | |
Completed |
NCT01884168 -
Study of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy
|